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Abstract
Introduction The dural sheath surrounding the optic nerve
communicates with the subarachnoid space, and distends when
intracranial pressure is elevated. Magnetic resonance imaging
(MRI) is often performed in patients at risk for raised intracranial
pressure (ICP) and can be used to measure precisely the
diameter of optic nerve and its sheath. The objective of this
study was to assess the relationship between optic nerve sheath
diameter (ONSD), as measured using MRI, and ICP.
Methods We conducted a retrospective blinded analysis of
brain MRI images in a prospective cohort of 38 patients
requiring ICP monitoring after severe traumatic brain injury (TBI),
and in 36 healthy volunteers. ONSD was measured on T2-
weighted turbo spin-echo fat-suppressed sequence obtained at
3 Tesla MRI. ICP was measured invasively during the MRI scan
via a parenchymal sensor in the TBI patients.
Results Measurement of ONSD was possible in 95% of cases.
The ONSD was significantly greater in TBI patients with raised
ICP (>20 mmHg; 6.31 ± 0.50 mm, 19 measures) than in those
with ICP of 20 mmHg or less (5.29 ± 0.48 mm, 26 measures; P
< 0.0001) or in healthy volunteers (5.08 ± 0.52 mm; P  <
0.0001). There was a significant relationship between ONSD
and ICP (r = 0.71, P < 0.0001). Enlarged ONSD was a robust
predictor of raised ICP (area under the receiver operating
characteristic curve = 0.94), with a best cut-off of 5.82 mm,
corresponding to a negative predictive value of 92%, and to a
value of 100% when ONSD was less than 5.30 mm.
Conclusions When brain MRI is indicated, ONSD
measurement on images obtained using routine sequences can
provide a quantitative estimate of the likelihood of significant
intracranial hypertension.
Introduction
Raised intracranial pressure (ICP) is frequent in conditions
such as stroke, liver failure, meningitis, meningoencephalitis
and postresuscitation syndrome [1-6]. In such diseases,
raised ICP may be associated with increased mortality and
poor neurological outcomes as a result of ischaemic insults to
the brain [4,7]. Early detection and treatment of raised ICP is
therefore critical but often challenging, because invasive ICP
monitoring is not routinely undertaken in these settings. How-
ever, magnetic resonance imaging (MRI) is often undertaken in
such patients, and may provide a noninvasive method of esti-
mating ICP. The optic nerve, as a part of the central nervous
system, is surrounded by a subarachnoid space and experi-
ences the same pressure changes as the intracranial compart-
ment [8-11]. The intraorbital part of the sheath, and particularly
its retrobulbar segment, can distend when ICP (and hence
cerebrospinal fluid [CSF] pressure) is elevated. MRI can be
used to measure precisely the diameter optic nerve and its sur-
rounding sheath, by using a fat-suppressed T2-weighted
sequence [12,13]. In cases of idiopathic intracranial hyperten-
sion or papilloedema, the retrobulbar optic nerve sheath diam-
eter (ONSD), measured using MRI, has been reported to be
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enlarged [14]. Moreover, in cases of hypotension in the CSF,
ONSD was found to be reduced [15]. However, the precise
correlation between MRI-determined ONSD and invasive ICP,
which remains the 'gold standard' for ICP measurement, has
never been studied. Such a comparison is essential to cali-
brate the MRI estimation of ICP and to define thresholds for
diagnosing intracranial hypertension.
In our institution, brain MRI studies are performed for research
purposes during the acute phase of traumatic brain injury
(TBI), with a substantial proportion performed in sedated and
mechanically ventilated patients with invasive ICP monitoring.
We therefore undertook a retrospective analysis of MRI scans
in a cohort of TBI patients with ICP monitoring in order to study
the relationship between ONSD and ICP and to assess the
diagnosis accuracy of ONSD for the detection of raised ICP.
MRI scans obtained from healthy volunteers were also studied
to define normal values for optic nerve and ONSD.
Materials and methods
Patients
This study was a retrospective analysis of data collected pro-
spectively between October 2006 and April 2008 from severe
TBI patients with postresuscitation Glasgow Coma Scale
score of 8 or less, who required sedation, mechanical ventila-
tion and ICP monitoring. All patients were treated with proto-
col driven therapy aimed to maintain ICP below 20 mm Hg and
cerebral perfusion pressure between 60 and 70 mmHg [16].
Patients were sedated using intravenous propofol and fenta-
nyl, and were mechanically ventilated. Patients were eligible
for inclusion if they had undergone MRI, including a T2-
weighted sequence, within 1 week of injury. Injury Severity
Score and Simplified Acute Physiology Score II were calcu-
lated from values obtained at day 1 after patient arrival [17,18].
Next of kin assent was obtained in all cases. Ethical approval
was obtained from the local research ethics committee. Age-
matched control individuals (healthy volunteers recruited from
the local community by advertisement) who underwent an
identical imaging protocol during the same period were also
studied. Exclusion criteria for healthy volunteers included a his-
tory of psychiatric or physical illness (particularly cardiovascu-
lar or neurological disorders), head injury and any history of
drug or alcohol dependence, as well as contraindications for
MRI.
Intracranial monitoring
ICP was continuously measured in TBI patients via an intrapa-
renchymal probe (Codman & Shurlett Inc., Ryanham, MA,
USA) inserted into the frontal lobe via Technicam Cranial
Access® device (Technicam Ltd, Newton Abbot, UK) by a neu-
rosurgeon. During MRI, the ICP transducer and excess wire
were located outside the receive head coil, as has previously
been described to be safe and not to cause heating [19]. ICP
was continuously monitored during MRI, and readings were
collected on a monitoring chart every 10 minutes. The ICP
value corresponding to the exact time of acquisition of the T2-
weighted MRI sequence was recorded. Raised ICP was
defined as ICP above 20 mmHg.
Imaging protocol
MRI in all individuals was performed using a 3T Magnetom
Total Imaging Matrix Trio (Siemens Medical Solutions, Munich,
Germany). The axial proton density/T2-weighted turbo spin-
echo fat-suppressed sequence was used to measure ONSD
and optic nerve diameter (OND). The scan parameters were
as follows: repetition time 4,600 ms, echo time 12 ms, pixel
bandwidth 185 Hz/pixel, slice thickness 4 mm, spacing
between slices 5 mm, and number of slices 27. The optic
nerve sheath appeared as a high signal surrounding a region
of low signal corresponding to the optic nerve (Figure 1). The
axial image slice that provided the best view of the ONSD was
chosen and the slice was interpolated to 1,000 × 1,333 pixels
using Image J 1.38 (National Institutes of Heath, Bethesda,
MD, USA). The retrobulbar area was zoomed to 300×, and
then ONSD and OND were measured in an axis perpendicular
to the optic nerve, 3 mm behind the globe using an electronic
caliper. The OND and the ONSD values obtained from both
sides were averaged for comparison with ICP measurements.
Computed tomography (CT) classification was determined
from the head CT scan obtained on admission. CT findings
were classified as described by Marshall and coworkers [20]:
diffuse injury (DI) category I corresponds to no visible intracra-
nial damage on CT scan; DI category II corresponds to a mid-
line shift of 0 to 5 mm; DI category III corresponds to absent
or compressed cisterns, with a midline shift of 0 to 5 mm; DI
category IV corresponds to a midline shift of more than 5 mm;
evacuated mass lesion (EML) corresponds to any surgically
evacuated lesion; and nonevacuated mass lesion (NEML) cor-
responds to a high-density or mixed-density lesion more than
25 mm in diameter and not surgically evacuated.
Statistical analysis
Statistical analyses were conducted using Statview (Statview
5.0 software; SAS Institute Inc., Cary, NC, USA). After assess-
ment for normality, parametric comparisons were performed
using two-tailed Student's t-test. Proportions were compared
using χ2 test. To evaluate the diagnostic accuracy for raised
ICP, receiver operating characteristic (ROC) curves were pro-
duced for ONSD and OND using Medcalc 9.1 Software
(Frank Schoonjans, Mariakerke, Belgium). Values are
expressed as means ± standard deviation otherwise specified,
and  P  values < 0.05 were considered to be statistically
significant.
Role of funding sources
The sponsors of this study and the funding sources played no
role in the study design, data collection, data analysis, data
interpretation, or writing of the report.Available online http://ccforum.com/content/12/5/R114
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Results
Study population
Thirty-eight TBI patients were studied. Seven of them had two
MRI studies during the acute phase of TBI, resulting in 45
scans with ICP monitoring. ONSD and OND measurements
were possible for both sides in 97% in TBI patients (only left-
sided measurements were possible in one patiennt). Thirty-
seven healthy volunteers were initially studied. One was
excluded because of lack of adequate view of both optic
nerves. In two other cases, ONSD and OND were only meas-
ured on one side. The overall feasibility of measuring ONSD
and OND was therefore calculated as 95% (78/82 scans cor-
responding to 72/75 individuals). Demographic characteris-
tics of the population are presented in Table 1.
Optic nerve sheath and optic nerve diameters
The mean ONSD in the TBI population was 5.72 ± 0.71 mm,
ranging from 4.38 to 7.25 mm. The mean ONSD in healthy vol-
unteers was significantly lower (5.08 ± 0.52 mm; P = 0.0001).
The ONSD was significantly higher in TBI patients with raised
ICP (>20 mmHg; 6.31 ± 0.50 mm, n = 19) than in TBI patients
with ICP of ≤ 20 mmHg (5.29 ± 0.48 mm, n = 26; P < 0.0001)
and in healthy volunteers (P < 0.0001). ONSD in TBI patients
with ICP of ≤ 20 mmHg and in healthy volunteers were not sig-
nificantly different (P = 0.12).
The mean OND in the TBI population was 2.65 ± 0.28 mm,
ranging from 2.12 to 3.27 mm, and was not significantly differ-
ent from that in healthy volunteers (2.70 ± 0.23 mm; P = 0.26).
OND did not differ between the TBI patients with raised ICP
(2.74 ± 0.23 mm) and those with normal ICP (2.58 ± 0.29
mm; P = 0.10) and healthy volunteers (P = 0.71).
Relationship between optic nerve sheath diameter, optic 
nerve diameter and intracranial pressure
The mean ICP in TBI patients was 18.7 ± 5.7 mmHg, ranging
from 7 to 34 mmHg. A significant and strong linear relationship
was found between ONSD and ICP (r = 0.71, P < 0.0001;
Figure 2a). The 95% confidence limit for the prediction of ICP
using ONSD was 9 mmHg. A weaker relationship was found
between OND and ICP (r = 0.38, P = 0.01; Figure 2b).
Optic nerve sheath diameter to detect raised intracranial 
pressure
ONSD accurately predicted an ICP greater than 20 mmHg
(area under ROC curve = 0.94, 95% confidence interval =
0.86 to 1.01; P = 0.0001; Figure 3). The best cut-off value of
ONSD for detecting raised ICP was 5.82 mm, with a sensitiv-
ity of 90%, a specificity of 92% and a negative predictive value
of 92%. One hundred per cent sensitivity and negative predic-
tive values were achieved for a 5.30 mm ONSD cut-off. How-
ever, OND did not accurately predict raised ICP (area under
ROC curve = 0.68, 95% confidence interval = 0.53 to 0.84;
P = 0.05). These two ROC curves were significantly different
(P = 0.001).
Inter-observer variability
The inter-observer variability in OND and ONSD measurement
was assessed by comparing measurements of ONSD and
OND in TBI and healthy volunteers. The observers (TG and
VN) were blinded to each other's findings, to ICP and to sub-
jects' identity. The inter-observer variability was tested on 23
randomly selected MRI datasets, corresponding to 22 individ-
uals (12 healthy volunteers and 10 TBI patients). The mean
standard deviation for ONSD was 0.17 mm, and the mean dif-
Figure 1
Methodology to measure ONSD and OND Methodology to measure ONSD and OND. OND, optic nerve diameter; ONSD, optic nerve sheath diameter.Critical Care    Vol 12 No 5    Geeraerts et al.
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ference between observers for ONSD was 0.11 mm (Table 2).
The agreement between observers is presented in Figure 4.
Discussion
This study shows that MRI using ONSD measurement is
potentially useful in detecting raised ICP. ONSD (but not
Table 1
General and intracranial characteristics of patients and healthy volunteers.
Characteristics Brain-injured patients Healthy volunteers P value
Number of patients 38 36 -
Number of scans 45 36 -
Age (years) 35 ± 14 32 ± 8 0.37
Weight (kg) 86 ± 14 75 ± 10 0.0003
Sex (% male) 80% 75% 0.82
Overall ICU length of stay (days) 17 ± 9 - -
SAPS II score 21 ± 6 - -
Injury Severity Score (median [range]) 25 (9–50) - -
Glasgow Coma Score (median [range]) 7 (3–8) - -
Intracranial pressure (mmHg; [range]) 18.7 ± 5.6 (7–34) - -
Optic nerve sheath diameter (mm) 5.72 ± 0.71 5.08 ± 0.52 0.0001
Optic nerve diameter (mm) 2.65 ± 0.28 2.70 ± 0.23 0.26
Head CT scan (Marshall's category; % of patients)
DI category I 0% - -
DI category II 55% - -
DI category III 3% - -
DI category IV 0% - -
EML 39% - -
NEML 3% - -
Unless otherwise stated, values are expressed as mean ± standard deviation. DI, diffuse injury; EML, evacuated mass lesion; ICU, intensive care unit; NEML, 
nonevacuated mass lesion; SAPS, Simplified Acute Physiology Score.
Figure 2
Parenchymal ICP versus ONSD and OND Parenchymal ICP versus ONSD and OND. Presented is the relationship between parenchymal ICP and (a) ONSD and (b) OND. Linear regression 
analysis identified a strong and significant relationship between ICP and ONSD. ICP, intracranial pressure; OND, optic nerve diameter; ONSD, optic 
nerve sheath diameter.Available online http://ccforum.com/content/12/5/R114
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OND) is strongly related to ICP, a finding that reflects disten-
sion of the nerve sheath during increases in CSF pressure.
The negative predictive value of an ONSD under 5.82 mm for
having ICP above 20 mmHg is more than 90%.
The early detection of raised ICP can be very difficult when
invasive devices are not available. Clinical signs of raised ICP
such as headache, vomiting and drowsiness are not specific
and often difficult to interpret. In sedated patients, clinical
signs of raised ICP frequently appear late, when ischaemic
brain injury is already established [21]. Furthermore, a normal
CT scan does not exclude a raised ICP [22-24].
Fundoscopic evidence of papilloedema can provide useful evi-
dence of intracranial hypertension in cases of chronic raised
ICP [25]. However, experimental studies clearly show that
oedema of the optic disk requires a few days to develop and
resolve, making it a less useful clinical sign in settings where
there may be acute increases or dynamic changes in ICP [26].
However, papilloedama is a delayed consequence of chronic
CSF accumulation in the retrobulbar optic nerve dural sheath
due to raised pressure in CSF in cranial cavity, and direct
measurement of such CSF accumulation may provide an ear-
lier and more responsive measure of intracranial hypertension.
Optic nerve sheath distension could therefore be an earlier,
more reactive and more sensitive sign of raised ICP.
High-resolution MRI is accurate at measuring ONSD [27,28]
and has been proposed to detect raised ICP in idiopathic
hydrocephalus and to diagnose shunt malfunction
[12,14,29,30]. On T2-weighted sequences, water (and CSF)
exhibits a high signal (white). Fat and grey matter appear as
light grey, and white matter as dark grey. The perioptic CSF is
surrounded by orbital fat. Contrast between CSF and orbital
fat can be improved with fat suppression, increasing the image
resolution for the ONSD measurement [12,13]. We have con-
firmed the utility of this approach, and we provide – for the first
time – a quantitative estimate of the relationship between MRI-
determined ONSD and ICP. Perhaps more importantly, our
data also provide predictive thresholds that enable the exclu-
sion of significant intracranial hypertension. In this context,
MRI-derived measurement of ONSD has a low inter-observer
variability (less than 0.2 mm), which is substantially less than
the mean difference in the measurement between raised ICP
and normal ICP patients (1.02 mm) and healthy volunteers
(1.23 mm). As a screening test, the technique has a high sen-
sitivity and negative predictive value. For an ONSD cut-off of
5.82 mm, the sensitivity and negative predictive value were
90% and 92%, respectively. A lower cut-off of 5.30 mm
resulted in a sensitivity and negative predictive value of 100%
for a diagnosis of significant intracranial hypertension, but at
the cost of a reduction in specificity to 50%. The most useful
clinical message derived from our data may be the following
thresholds; an ONSD less than 5.30 mm is unlikely to be asso-
ciated with raised ICP, and an ONSD above 5.82 mm indi-
cates that the probability of raised ICP is 90%. However, OND
had a weaker positive relationship with ICP. Therefore, the
increase in ONSD during raised ICP cannot be related only to
optic nerve dilatation (as during optic nerve oedema) but also,
and predominantly, to its optic nerve sheath distension, prob-
ably caused by increased CSF pressure around the optic
nerve.
In the present study, TBI patients have significantly greater
weights than healthy volunteers (P = 0.0003). Because optic
Figure 3
ROC curves for ONSD and OND with respect to raised ICP ROC curves for ONSD and OND with respect to raised ICP. 'Raised 
ICP' is defined as an ICP above 20 mmHg identified during T2-
weighted magnetic resonance imaging. ICP, intracranial pressure; 
OND, optic nerve diameter; ONSD, optic nerve sheath diameter; ROC, 
receiver operating characteristic.
Table 2
Inter-observer variability for optic nerve (and sheath) diameters
Optic nerve diameter Optic nerve sheath diameter
Mean standard deviation (mm) 0.25 0.17
Mean difference (mm) 0.30 0.11
The inter-observer variability was tested in 23 randomly selected magnetic resonance imaging datasets.Critical Care    Vol 12 No 5    Geeraerts et al.
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nerve diameters may be related to body size, this could induce
a significant bias. However, body weights in TBI patients with
raised ICP (n = 14) were not significantly different from those
without raised ICP (n = 24; respectively, 89.0 ± 15.8 kg and
84.1 ± 12.6 kg; P = 0.3). The differences observed in ONSD
between TBI patients with and without raised ICP can there-
fore not be attributed to differences in body weight.
A major limitation of this study is probably related to MRI by
itself, with limited access, necessity of patient transfer in a
magnetic area and specific contraindications. Moreover, in the
present study, the slice thickness and interslice spacing were
relatively large (4 and 5 mm, respectively). The optic nerve and
its sheath were therefore apparent in only one or two slices of
the T2-weighted turbo spin-echo sequence. MRI protocols
using thinner slices or three-dimensional volumetric acquisi-
tion could probably increase the precision of the measurement
of ONSD. Consequently, this test should not be used to pre-
dict the exact value of ICP but to estimate the probability of
intracranial hypertension.
Developing a reliable measurement of ONSD is of interest. In
humans, noninvasive assessment of ICP using ocular sonog-
raphy and ONSD measurement has been proposed in cases
of hydrocephalus, hepatic failure and TBI [8,10,31-36]. Inter-
estingly, the best cut-off value for raised ICP using ocular
sonography was 5.7 to 5.8 mm, which is very close to the fig-
ure identified in the present study (5.8 mm). This study corrob-
orates findings obtained with ocular sonography and provides
evidence for the use of ONSD measurement when brain MRI
is performed in situations that potentially can lead to raised
ICP. Proton density/T2-weighted turbo spin-echo is a conven-
tional sequence, lasting less than 3 minutes, which forms part
of most routine clinical MRI studies. ONSD measurement
could provide important clinical information on the likelihood of
intracranial hypertension, and it may help to identify those
patients who require more invasive monitoring.
Conclusion
In sedated TBI patients, ONSD measured using conventional
brain T2-weighted MRI strongly correlates with invasive ICP.
An ONSD above 5.82 mm is associated with a 90% probabil-
ity of significant intracranial hypertension, whereas the proba-
bility of not having significant intracranial hypertension is 90%
if the ONSD is under 5.82 mm and 100% if it is less than 5.30
mm. When MRI is indicated, ONSD can easily be measured
on routine sequences, and provides a quantitative estimate of
the likelihood of significant intracranial hypertension.
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